A Multicenter Dose Ranging Clinical Trial of 2',3'-Dideoxycytidine in the Treatment of Patients With AIDS and Advanced ARC.

NCT00000704 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

64

Enrollment

NIH

Sponsor class

Conditions

HIV Infections

Interventions

DRUG: Zalcitabine

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)